Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) has a thin disclosure history in our data (latest filing: 3 March 2022). New filings will appear here as soon as they are published. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Analysts rate Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) Hold (neutral).
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
1 of 1 declaration
Bausch Health Companies Inc. is a healthcare and pharmaceutical company focused on the development and commercialization of pharmaceutical products and medical devices. Formerly known as Valeant Pharmaceuticals International, Inc., it is listed on the Toronto Stock Exchange.
Headquarters: Laval, Canada · Founded: 1960 · Wikipedia article
Source: Wikidata (CC0).